We are in the middle of a CHO revolution where gene editing can offer a significant change in biopharmaceutical manufacturing.
Three researchers from The Novo Nordisk Foundation Center for Biosustainability (CFB) have each been granted more than 2.5 Mio. DKK by the Novo Nordisk Foundation for projects regarding biotechnological synthesis and production of high value chemicals and pharmaceuticals.
What on earth have Chinese hamsters to do with medical drugs? Quite a lot as it turns out, as hamster cells can be programmed to sustainably produce anti-cancer drugs, among other things.
All students enrolled in DTU Biosustain's new course ‘Advanced Experimental Synthetic Biology’ have now passed the exam brilliantly. Overall the course was a great success, according to the instructors.